Celestine antibodies carrying a lymphocyte T cell toward the tumor and presenting it to it, by Wearbeard (2021)

Anticuerpos-celestina-la-cuarta-rama-de-la-inmunoterapia-contra-el-cancer.png

Title

Celestine antibodies carrying a lymphocyte T cell toward the tumor and presenting it to it, by Wearbeard (2021)

Creator

Wearbeard (Unknown)

Date

2021

Description

The illustration shows a heart nailed in a mass that represents a tumor, and a blue channel that connects the two with a figure of an old woman reminiscent of Celestina. This illustration represents how the so-called celestine antibodies work. These antibodies created in the laboratory could perform different functions "Among these, for example, binding its other end to a killer T lymphocyte, activate it and direct it towards a target chosen to eliminate it. For example, a tumor cell. They are celestine antibodies because they carry them to the tumor and they present it to it, provoking a fatal love." (translated description by:
https://www.agenciasinc.es/Reportajes/Anticuerpos-celestina-la-cuarta-rama-de-la-inmunoterapia-contra-el-cancer, Archived in:  https://web.archive.org/web/20211217103657/https://www.agenciasinc.es/Reportajes/Anticuerpos-celestina-la-cuarta-rama-de-la-inmunoterapia-contra-el-cancer).

Source

Illustration by Wearbeard for the article "Anticuerpos celestina, la cuarta rama de la inmunoterapia contra el cáncer" ("Celestine antibodies, the fourth branch of cancer immunotherapy"), by Jesús Méndez, published in Servicio de Información y Noticias Científicas (SINC), Farmacología, December 11, 2021:
https://www.agenciasinc.es/Reportajes/Anticuerpos-celestina-la-cuarta-rama-de-la-inmunoterapia-contra-el-cancer

Archived in:
https://web.archive.org/web/20211217103657/https://www.agenciasinc.es/Reportajes/Anticuerpos-celestina-la-cuarta-rama-de-la-inmunoterapia-contra-el-cancer

Format

Illustration.
Dimensions: Unknown.

Related items

This element has no related elements.

Embed item in your website

To incorporate this Item on your web page, copy the code provided below: